MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCEV. Ribrag,P. Feugier,J. Doorduijn,M. Delfau‐Larue,O. Hermine,H. Kluin‐Nelemans, M. Dasilva, A. Lopez‐Hernandez,J. Walewski,M. Szymczyk,C. Pott,C. Homburg,V. Van der Velden,P. Gameiro, R. Garcia‐Sanz,M. Ladetto,H. van Krieken,J. Cabeçadas,G. Rymkiewicz,W. Klapper,E. Hoster,S. Le Gouill,M. DreylingHematological oncology（2017）引用 2|浏览67暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
